Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisN

Face transplants technically possible, but “very hazardous”

Jocalyn Clark
CMAJ February 03, 2004 170 (3) 323;
Jocalyn Clark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2004 Canadian Medical Association or its licensors

With new technologies in micro-surgery and antirejection drugs, facial transplantation is now technically possible, but British surgeons are being urged to hold off until the ethical issues are debated and more research into immunotherapy and psychological risks is conducted

Figure

Figure. From sci-fi to reality: Die Another Day henchman Zao (played by Rick Yune) in mid-transplant. Photo by: MGM Studios Inc.

The procedure is “highly experimental” and “appears to be very hazardous,” concludes a new report from the Royal College of Surgeons of England. The report also acknowledges that the treatment would “constitute a major breakthrough in restoration of quality of life to those whose faces have been destroyed by accident or tumour. Our conclusion does not underestimate the suffering of those patients who might be tempted by the prospect.”

Physicians in the US, UK and France say they are ready to do face transplants. The American and French teams are awaiting regulatory approval for the procedure.

Facial transplants involve removing facial muscles and skin from a cadaveric donor and placing them on a living person. They do not result in the recipient looking like the donor, however, the change in appearance can give rise to psychological issues surrounding identity.

Plastic surgeons view face transplants as an advancement over reconstructive surgery, which results in a mask-like appearance. Transplants provide some movement and sensitivity, allowing the patients to convey feelings and smile.

Dr. Peter Butler is the consultant plastic surgeon at London's Royal Free Hospital whose claim last year that 10 people had requested facial transplantation sparked the convening of the College's working party. He now says that it would be unwise at present to proceed. “From a surgical point of view we're ready. We've worked out what an ideal patient would be,” he told CMAJ. “But we agree that the psychological impacts and the issue of immunosuppression still need to be debated” before any procedure takes place.

“For facial transplantation to take place before this is done would be a step backwards rather than a step forward.”

All transplant recipients require a lifetime of immunosuppressive drugs, which may shorten life-span. Dr. James Partridge, founder and chief executive of Changing Faces, a charity that helps people with facial disfigurement, wonders if this risk is appropriate for a procedure that does not preserve or prolong life. “We must be very clear about the side effects of the immunosuppression drugs before we proceed.”

Psychologically, the disruption to the recipient's facial appearance and their concept of self-identity may result in a major life crisis, particularly in those with unrealistic expectations. “What would it mean for a person to have a different face?” asked Partridge, who emphasizes the need for more research and debate.

One of the problems, Butler said, is that “we really won't know the full impact until we do it on a human being.”

The college report concludes that: “It also remains unclear how acceptable and valid consent can be obtained from potential recipients, given the uncertainties about the risks and benefits .”

Butler, who rejected the suggestion that a “race for the face” had developed between his group and the 2 Kentucky-based teams, concedes that because of resources and infrastructure “the American group is probably the closest.” In fact, he stated that “they are already assessing patients for facial transplantations.”

The Royal College of Surgeons of England welcomes comments on its Facial Transplantation: Working Party report (www.rcseng.ac.uk) until Feb. 27. — Jocalyn Clark, London, UK

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 170 (3)
CMAJ
Vol. 170, Issue 3
3 Feb 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Face transplants technically possible, but “very hazardous”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Face transplants technically possible, but “very hazardous”
Jocalyn Clark
CMAJ Feb 2004, 170 (3) 323;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Face transplants technically possible, but “very hazardous”
Jocalyn Clark
CMAJ Feb 2004, 170 (3) 323;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Until they have faces: the ethics of facial allograft transplantation
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Medical ethics
    • Transplant medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire